Results 151 to 160 of about 23,885,267 (262)

Partial FAK suppression promotes tumor growth, an effect reversed by macrophage p110δ PI3K inactivation

Molecular Oncology, EarlyView.
Partial inhibition of focal adhesion kinase (FAK) can paradoxically promote tumor growth, rather than simply producing a weaker antitumor effect than that observed with strong FAK suppression. In breast cancer and melanoma models, targeting p110δ PI3K, particularly in macrophages, counteracted these tumor‐promoting effects, highlighting the importance ...
Lydia Xenou, Niki Tzenaki, Anna Tsapara, Maria Tzardi, Evangelia A. Papakonstanti   +4 more
wiley   +1 more source

Quarterly Report to the Technology Assessment Board, January 1 - March 31, 1991

, 1991
This is a quarterly report detailing the budget and progress of the Office of Technology ...
Office of Technology Assessment
core  

Role of General Practitioners in European Health Technology Assessment, EU-HTA Innovation in Oncology as an Example. [PDF]

J Mark Access Health Policy
Widmer D, Marcos Carrera H, Ruof J, Fernando GVC, Ouvrard P, Bonnamour MC, McCarthy M, Atreya S.   +7 more
europepmc   +1 more source

Mechanisms and therapeutic opportunities of the ribotoxic stress response in cancer

Molecular Oncology, EarlyView.
Cancer cells' high translational demand creates opportunities to therapeutically target ribosome function. Ribosome stalling and collisions activate ZAKα and the ribotoxic stress response (RSR), which can trigger rapid, p53‐independent apoptosis in cancer.
Anastassiya Kim, Maryam Aslam, Elouise Torruella, Alphons Sony, Asif Rahman, Simira Smith, Columba de la Parra, Moira Sauane   +7 more
wiley   +1 more source

Office of Technology Assessment FY1994 Annual Report to Congress, March 1995

, 1995
The Office of Technology Assessment (OTA) is a nonpartisan congressional support agency of the United States congress. OTA is charged with advising the Congress on a wide range of critical issues involving science and technology.
Office of Technology Assessment
core  

Next-generation methods in health technology assessment (HTA): need, rigor, and implementability. [PDF]

Int J Technol Assess Health Care
Richardson M, Augustovski F, Pegg M, Seck C, Kar SS, Goettsch W.   +5 more
europepmc   +1 more source

Profiling neoadjuvant therapy response in rectal cancer using meta‐analysis of publicly available transcriptomic RNA‐seq datasets

Molecular Oncology, EarlyView.
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic, Rafael Stroggilos, Mladen Marinkovic, Ana Djuric, Suzana Stojanovic‐Rundic, Radmila Jankovic, Sergi Castellvi‐Bel, Remond J.A. Fijneman, Antonia Vlahou, Jerome Zoidakis, Milena Cavic   +10 more
wiley   +1 more source

Quarterly Report to the Technology Assessment Board, October 1 - December 31, 1980

, 1981
This is a quarterly report detailing the budget and progress of the Office of Technology ...
Office of Technology Assessment
core  

Rethinking Slovenia's HTA System. [PDF]

Int J Technol Assess Health Care
Hren R.
europepmc   +1 more source

Gut microbiota alterations in patients with non‐small‐cell lung cancer undergoing chemoradiotherapy

Molecular Oncology, EarlyView.
We investigated the impact of concurrent chemoradiotherapy (CRT) on the gut microbiota in patients with locally advanced non‐small‐cell lung cancer. Overall gut microbiota composition remained largely stable throughout CRT while antibiotic exposure may influence microbial diversity.
Hanne Marte Nymoen, Zhi Zhao, Henrik Horndalsveen, Maria Moksnes Bjaanæs, Bjørn Henning Grønberg, Tarje Halvorsen, Tesfaye Madebo, Marianne Aanerud, Jussi Koivunen, Kersti Oselin, Saulius Cicenas, Nina Helbekkmo, Jarkko Ahvonen, Maria Silvoniemi, Tine Norman Alver, Tonje Dalen, Åsa Kristina Öjlert, Saima Jamil Farooqi, Åslaug Helland, Vilde Drageset Haakensen   +19 more
wiley   +1 more source